Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival

BACKGROUND: The innovative combination of all‐trans retinoic acid (ATRA) and arsenic trioxide (ATO) has established a new chapter of curative approach in acute promyelocytic leukemia (APL). The disease characteristics and prognostic influence of additional cytogenetic abnormalities (ACA) in APL with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Hui, Dong, Hai‐Bo, Zhang, Qi‐Guo, Zhou, Min, Zhang, Qian, Chen, Lan‐Xin, Yuan, Cui‐Ying, Jiang, Ru‐Ru, Liu, Jin‐Wen, Ou‐Yang, Jian, He, Jie, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524065/
https://www.ncbi.nlm.nih.gov/pubmed/37584196
http://dx.doi.org/10.1002/cam4.6398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524065/
https://www.ncbi.nlm.nih.gov/pubmed/37584196
http://dx.doi.org/10.1002/cam4.6398

Ejemplares similares